SignalFire · 22 October 2026

Why we're betting on Warp Sciences to accelerate U.S. drug discovery

SignalFire

SignalFire invests in Warp Sciences, an automated chemistry CRO bringing drug-discovery R&D in-house to the U.S. The company combines AI-driven experiment design, robotics, and proprietary data generation to overcome the manual bottleneck in preclinical drug discovery and compete with overseas outsourcing.

Read the full post ↗

Topics: Biotech & Life Sciences · AI Infrastructure

SandHill indexes 800+ venture capital blogs and newsletters and sends the best of them every Sunday. Browse the sources · browse by topic · read the blog.